BHPP3-R— Peptide Research Compound

Catalog ID: BHPP3-R | CAS: 2381089-83-2 | Sequence: Synthetic triagonist analog (GLP-1/GIP/Glucagon receptor agonist)

Compound Overview

BHPP3-R is a synthetic triagonist peptide designed to activate the GLP-1, GIP, and glucagon receptors.
It is provided in research-grade purity for laboratory studies investigating incretin receptor synergy, energy metabolism, and peptide receptor pharmacology.
Not for human consumption or therapeutic application.

Molecular Characteristics

• Synonyms: ; LY3437943; Triple-Agonist Incretin Analog
• CAS Number: 2381089-83-2
• Sequence: Synthetic linear analog of GLP-1/GIP/Glucagon receptor triagonist peptide
• Molecular Formula: C₂₂₉H₃₆₄N₅₆O₇₁
• Molecular Weight: ≈ 4958.8 g/mol
• Purity: ≥ 98% (HPLC)
• Formulation: Lyophilized peptide powder

Physical Properties

• Appearance: White to off-white lyophilized powder
• Solubility: Sterile water or 0.6 % acetic acid (for research use only)
• Container: Sterile sealed vial

Storage & Stability

• Unreconstituted: Store at −20 °C, protected from light and moisture.
• Reconstituted: Aliquot and store at −20 °C; avoid repeated freeze–thaw cycles.

Research Context

GLP3-R is utilized in in vitro and in vivo model systems to investigate triple-receptor signaling synergy across the GLP-1, GIP, and glucagon pathways.
Research focuses on its effects on energy homeostasis, receptor cross-talk, cAMP dynamics, and metabolic regulation at the molecular and cellular levels.
The compound serves as a valuable model for examining **polyagonist incretin biology** and **advanced peptide pharmacology**.